The Ectonucleotidases CD39 and CD73 and the Purinergic Receptor P2X4 Serve as Prognostic Markers in Non-Small Cell Lung Cancer
These findings underscore the importance of purinergic signaling in NSCLC prognosis and highlight the role of the ectonucleotidases CD39 and CD73 as potential therapeutic targets to enhance antineoplastic immune responses.
Authors
- Bernward Passlick (ORCID: https://orcid.org/0000-0002-4684-0625)
- Jannis Heyer
- Felix Kind (ORCID: https://orcid.org/0000-0002-9398-5747)
- António Eduardo Cabrita Figueiredo
- Peter Bronsert (ORCID: https://orcid.org/0000-0001-8558-0347)
- Konrad Kurowski (ORCID: https://orcid.org/0009-0009-0448-7999)
- Severin Schmid (ORCID: https://orcid.org/0000-0001-8077-082X)
- Martin Werner
- Sophie Nicole Prozmann
- K. Schröder
Institutions
- University of Freiburg (DE)
- University Medical Center Freiburg (DE)
Publication Details
- Journal
- Cancers
- Published
- 2025-03-28
- DOI
- https://doi.org/10.3390/cancers17071142
- Citations
- 2
- Primary Topic
- Adenosine and Purinergic Signaling
- Type
- article
- Field-Weighted Citation Impact
- 2.24